Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19

Journal:
Organic Letters
Published:
DOI:
10.1021/acs.orglett.5c03920
Affiliations:
3
Authors:
41
Institutions Authors Share
Merck - Rahway, United States of America (USA)
39.000000
39.000000
39.000000
39.000000
0.95
Changzhou SynTheAll Pharmaceutical, China
2.000000
0.05